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Solid-state NMREquinatoxin II (EqtII) is a pore-forming protein from Actinia equina that lyses red blood cell and model
membranes. Lysis is dependent on the presence of sphingomyelin (SM) and is greatest for vesicles composed
of equimolar SM and phosphatidylcholine (PC). Since SM and cholesterol (Chol) interact strongly, forming
domains or “rafts” in PC membranes, 31P and 2H solid-state NMR were used to investigate changes in the
lipid order and bilayer morphology of multilamellar vesicles comprised of different ratios of dimyristoylpho-
sphatidylcholine (DMPC), SM and Chol following addition of EqtII. The toxin affects the phase transition
temperature of the lipid acyl chains, causes formation of small vesicle type structures with increasing
temperature, and changes the T2 relaxation time of the phospholipid headgroup, with a tendency to order
the liquid disordered phases and disorder the more ordered lipid phases. The solid-state NMR results
indicate that Chol stabilizes the DMPC bilayer in the presence of EqtII but leads to greater disruption when
SM is in the bilayer. This supports the proposal that EqtII is more lytic when both SM and Chol are present as
a consequence of the formation of domain boundaries between liquid ordered and disordered phases in lipid
bilayers leading to membrane disruption.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Equinatoxin II (EqtII) is a 179 residue protein from the Mediter-
ranean sea anemone Actinia equina that forms pores in red blood cells
and is a member of the actinoporin class of pore-forming toxins [1].
Actinoporins are a class of eukaryotic pore-forming toxins found
exclusively in sea anemones and, like bacterial toxins, are proteins
that act by the formation of pores in the targeted membrane. Pore
formation by EqtII occurs via a multi-step mechanism, which includes
membrane binding, protein oligomerization and insertion of the N-
terminus [2]. The initial binding step, which is relatively non-speciﬁc,
involves interaction between the lipid membrane and a cluster of
exposed aromatic residues. In the presence of sphingomyelin (SM),
EqtII undergoes a second binding step where it inserts more deeply
into the membrane and is anchored by the N-terminal region [3].
During pore formation the N-terminal region appears to remainholesterol; CSA, chemical shift
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ll rights reserved.helical, increasing from ∼15 residues in native EqtII to ∼22 residues in
the membrane associated N-terminal peptide [4], penetrating the
membrane at an angle of approximately 21° to the bilayer normal [2].
A speciﬁc lipid interaction with SM has been proposed to drive EqtII
binding [5]. In addition, EqtII has been shown to associate at domain
boundaries between ordered and disordered phases, as seen in SM/
phosphatidylcholine/cholesterol monolayers, and this association
may promote oligomerization in membranes [6].
Although the structural changes of EqtII upon membrane binding
and oligomerization have not been characterised in detail, in order to
understand the mechanism of pore formation and cytotoxicity the
effect of the toxin on phospholipid bilayers has been examined [7,8].
Earlier solid-state NMR studies from our group [7] reported the effect
of the addition of EqtII (at 1:1000 or 1:250) on dimyristoylpho-
sphatidylcholine (DMPC) and DMPC:SM (10:1) bilayers, which show
only minimal lysis. EqtII affected the lipid dynamics and resulted in
disruption of the mixed phospholipid bilayer and formation of small
vesicles (visualized by electron microscopy) that produced an
isotropic peak in the NMR spectra. By contrast, electron micrographs
of EqtII (at 50:1) in palmitoyloleoylphosphatidylcholine (POPC):SM
(2:1) bilayers appeared to show toroidal pores [8]. These different
effects could be due to differences in membrane ﬂuidity or order
between the DMPC and POPC bilayers or domain formation at higher
SM content.We now report a solid-state NMR study of the effect of the
toxin on DMPC bilayers with higher SM content.
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of membrane lipids [9]. The effect of EqtII on deuterated phospholipid
bilayers was probed further by 31P and 2H solid-state NMR
spectroscopy. 31P NMR is a sensitive reporter of changes in the
lipid–water interface environment and phospholipid dynamics and
phase [10]. Similarly, 2H NMR of chain perdeuterated lipids gives
insight into changes in chain order and dynamics [11]. Changes in
lipid dynamics can be probed by NMR relaxation times, primarily the
transverse relaxation time (T2), which reports on low-frequency
motions; and the spin-lattice or longitudinal relaxation time, (T1),
which reports on higher-frequency motions on the μs to ns timescale
[12].
Since recent studies using ﬂuorescence confocal microscopy have
shown that EqtII tends to accumulate in the phase boundaries
between liquid ordered and disordered phases [13], we have
investigated the effect of EqtII on the order and phase of mixed
DMPC, SM and cholesterol (Chol) bilayers over a range of tempera-
tures. The following lipid compositions were chosen: DMPC:SM (1:1),
in which EqtII activity is optimal, DMPC:SM:Chol (1:1:1) for bilayers
likely to produce phase separation or domain formation and,
therefore, phase boundaries, and DMPC:Chol (1:1) and (2:1) to
determine the effect of cholesterol and SM. Understanding the effect
of EqtII on mixed lipid bilayers may lead to better understanding of
the lytic process by other pore-forming toxins.
2. Materials and methods
2.1. Equinatoxin II and lipids
EqtII was expressed in Escherichia coli BL21(DE3) strain and
isolated from bacterial cytoplasm, as described previously by
Anderluh et al. [14]. Brain sphingomyelin (SM) and chain perdeut-
erated dimyristoylphosphatidylcholine (DMPC-d54) from Avanti Polar
Lipids (Alabaster, USA) and cholesterol (Chol) from Sigma (St Louis,
USA) were used as shipped without further puriﬁcation. Deuterated
chloroform (CDCl3) was obtained from Sigma (St Louis, USA).
2.2. Sample preparation of hydrated dispersions
Lipids were dissolved in chloroform/methanol (3:1, v/v) and
combined at the appropriate molar ratio to produce 10 mg of lipid per
sample. The solvents were removed by rotary evaporation and the
sample pumped under a high vacuum overnight. The samples were
hydrated to a total volume of 200 μL with de-ionized water or with
EqtII in water to give the desired toxin:lipid ratio. Dilute HCl or NaOH
was used to adjust the pH to 5.5 or 7.0. The following lipidmolar ratios
were prepared: DMPC:SM (1:1), DMPC:Chol (1:1), DMPC:Chol (2:1)
and DMPC:SM:Chol (1:1:1); and EqtII/lipid molar concentrations of
both 1:1100 and 1:250 were examined. The hydrated sample was
vortexed and put through at least four freeze–thaw cycles, involving
rapid freezing in liquid nitrogen and equilibrating in warm water at
50 °C, to produce multilamellar vesicle (MLV) suspensions. The
sample was then centrifuged in a bench-top centrifuge (15000 rpm
for 30 min at 4 °C) to produce a lipid pellet and 150 μL of excess water
was removed. The lipid pellet was loaded directly into 5 mm NMR
tubes for wideline NMR experiments. After acquisition of the static
NMR spectra, the 50 μL samples were again centrifuged and ∼30 μL of
clear supernatant removed. The hydrated lipid pellets were trans-
ferred to 5 mm MAS rotors for 31P MAS NMR experiments, including
T2 determination.
2.3. SDS-polyacrylamide gel
The amount of EqtII in the supernatantwas estimated using sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), by
comparison of band intensity against a standard 1.0 mg/mL EqtIIsample. SDS-PAGE gels were prepared as described previously [15]
and visualized using Coomassie Blue stain.
After SDS-PAGE was used to determine the concentration of
soluble EqtII in the supernatant, the remainder of the supernatant was
lyophilized, weighed and re-suspended in CDCl3/CD3OH. High-
resolution 31P NMR spectra were obtained to determine the ratio of
lipids in the supernatant.
2.4. NMR experiments
2.4.1. Solid-state NMR
Static 31P and 2H NMR and 31P magic angle spinning (MAS) NMR
experiments were carried out on a Varian (Palo Alto, USA) Inova 300
NMR spectrometer equipped with a Doty (Doty Scientiﬁc Inc.,
Columbia, USA) MAS probe operating at 121.5 and 46.1 MHz for 31P
and 2H, respectively. Wideline variable temperature spectra were
acquired at 5 °C intervals between 25 and 45 °C. MAS spectra and
transverse relaxation (T2) experiments were acquired at 25 °C and
45 °C. 31P resonances were referenced externally to phosphoric acid at
0 ppm.
2H spectra were obtained using a quadrupole or solid echo
sequence (π/2–τ–π/2–τ–acquire) [16], with inter-pulse delay τ of
40 μs, 250 kHz spectral width, 90° pulse length of 5 μs, a recycle time
of 0.5 s, and 58,000–100,000 transients. A line broadening of 100 Hz
was applied. The quadrupole splitting, ΔνQ, observed from each
deuterated methylene segment of the lipid acyl chains is a sensitive
probe for detecting changes in the overall order of the phospholipid
chains and is related to the order of the C-D bond, SCD,




where the quantity in brackets is the deuterium quadrupole coupling
constant, equal to 167 kHz for C–D bonds [17]. Thus SCD can be
determined from the observed splitting.
31P NMR was employed to gain information on the local order and
conformation in the phosphate region of the polar headgroup [18], as
well as the lipid polymorphic phase [19]. 31P static NMR spectra were
acquired with a standard spin-echo pulse sequence (π/2–τ–π–τ–
acquire) and proton decoupling, a spectral width of 62.5 kHz, a π/2
pulse of 4 μs, τ delay of 0.1 ms, a recycle time of 4.0 s and 7500–14000
transients. A line broadening of 100 Hz was applied. 31P MAS spectra
of the MLV dispersions were obtained in a 5 mm rotor spun at 7 kHz
under the same conditions but using a spectral width of 15 kHz. A line
broadening of 10 Hz was applied and 2500–3000 transients were
acquired.
2.4.2. Determination of 31P T2 relaxation times
The 31P relaxation time, T2, is dominated by slow motions,
primarily the correlation time for diffusion of the phospholipid in
the membrane bilayer. In MLV, correlation times for phospholipid
reorientation range between 8 and 40 ms [20, 21]. Spectra were
acquired using a spin echo pulse sequence (π/2–τ–π–τ–acquire) with
τ delays arrayed incrementally between 0.1 and 400 ms. For each
array, 5–15 τ values were acquired and 300–800 transients were
averaged. At least two experiments were done, each using a different
array of τ values. Where possible the peak intensities were
determined using the Varian software package, VNMR, but if a peak
was under the VNMR threshold the intensity was measured and
enteredmanually. Peak intensity versus twice the τ delay was plotted,
and either a single or double exponential curve ﬁtted using Excel
(Microsoft). The T2 values obtained for each experiment were
averaged and the range between these values reported.
2.4.3. Solution NMR spectroscopy
Solution spectra were acquired on a Varian Inova 400 NMR, using a
5 mm broad band probe, operating at 162 and 100 MHz for 31P and
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supernatant were obtained after freeze-drying the supernatant and
dissolving in CDCl3/CD3OH to determine the lipid composition of the
supernatant. Spectra were acquired at 25 °C with proton decoupling.
3. Results
The effects of EqtII on the 31P chemical shift anisotropy (CSA) of
the phospholipid headgroups and the 2H quadrupolar splittings (ΔνQ)
of the acyl chains of perdeuterated DMPC in mixed DMPC, SM and
Chol bilayers were determined.
3.1. MLV lipid dispersions
The 31P spectra of DMPC:SM (1:1), DMPC:Chol (1:1), DMPC:Chol
(2:1) and DMPC:SM:Chol (1:1:1) MLV at 25 and 45 °C are shown in
Fig. 1. At 25 °C a single 31P powder pattern was observed from both
phospholipid headgroups, DMPC and SM, for all lipid compositions
(Fig. 1), indicating that the lipid species are homogeneously mixed in
the lipid bilayer. However, the spectrum of DMPC:SM (1:1) was
different, with a less well deﬁned 0° edge (near 25 ppm) and a
narrower CSA (41 ppm) relative to the cholesterol containing
compositions DMPC:Chol (1:1), DMPC:Chol (2:1) DMPC:SM:Chol
(1:1), with CSA of 44, 49, and 52 (±1) ppm, respectively. The 31P
spectra are consistent with powder distributions of the lipid
phosphates with partial motional averaging due to fast axial rotation
of the phospholipid molecules, characteristic of lipids in the ﬂuid
bilayer phase in dispersions where the average size of the MLV
exceeds 1 μm [18].
As the temperature was increased from 25 to 45 °C, the spectral
shape remained similar for all cholesterol compositions, with a
reduction in width of ∼3 ppm due to the increased averaging of the
31P CSA (Fig. 1). The increase in intensity at the 90° edge of the CSA
(∼−15 ppm) at 45 °C (Fig. 1) indicates that the MLV are aligning in
the magnetic ﬁeld and the reduced CSA indicates an increase in
headgroup motion [22].
The small peak at 0 ppm evident in the spectra of DMPC:SM (1:1)
at 45 °C (Fig. 1) indicates the formation of a separate phase where the
phospholipids are undergoing faster, almost isotropic, motions, which
results in almost complete averaging of the 31P CSA. The formation of
this peak at 0 ppm suggests that at higher temperatures the DMPC:SM
(1:1) bilayer is less stable and, therefore, possibly more prone to EqtII
disruption than the DMPC:Chol (1:1) and (2:1) and DMPC:SM:Chol
(1:1:1) dispersions.
The 2H spectra of deuterated DMPC in the mixed lipid MLV are
shown in Fig. 2. The spectra of DMPC:Chol (1:1), DMPC:Chol (2:1) and
DMPC:SM:Chol (1:1:1) at 25 °C are characterized by quadrupole
splittings of 55, 55 and 57 kHz, respectively, from the most ordered
CD2 nearest the glycerol backbone. The quadrupolar splitting due to
each deuterium label down the acyl chain is directly proportional toFig. 1. 31P NMR spectra of MLV dispersions at 25 °C and 45 °C.the order parameter SCD for that carbon-deuterium bond [22], with
the inner-most 2H splitting of the spectrum assigned to the terminal
methyl group, being the most mobile or disordered group of the lipid
acyl chain.
The 2H spectrum of DMPC:SM (1:1) at 25 °C (Fig. 2) is different
from that of MLV containing cholesterol. The powder pattern of
DMPC:SM (1:1) is more rounded and typical of phospholipids in a
mixed phase, with a narrower quadrupolar splitting of 34 kHz
compared to ∼55 kHz for the cholesterol compositions. Themore ﬂuid
acyl chains were more disordered in the absence of cholesterol
compared to the liquid ordered phase of cholesterol-phospholipid
bilayers [23], as seen in Fig. 2. An increase in temperature to 45 °C
resulted in a small change in the 2H spectra of the cholesterol-
containing MLV dispersions. A reduction in the quadrupolar splitting
was evident, from 55, 55 and 57 kHz at 25 °C, to 53, 47 and 48 kHz at
45 °C, for DMPC:Chol (1:1), DMPC:Chol (2:1), and DMPC:SM:Chol
(1:1:1), respectively, indicating a decrease in the acyl chain order.
However, the DMPC:SM (1:1) powder spectrum (Fig. 2) is now
characteristic of a ﬂuid bilayer with a quadrupole splitting of 26 kHz,
i.e., in the absence of cholesterol the lipid acyl chains experience a
higher degree of disorder. The gel to ﬂuid phase transition occurred
between 30 and 35 °C (spectra not shown), which is roughly midway
between that of DMPC (22 °C) and SM (42 °C) and, together with the
2H powder spectra in Fig. 2, suggests that the lipids are homoge-
neously distributed.
3.2 DMPC:SM (1:1) in the presence of EqtII
The 31P spectra of the DMPC:SM (1:1) MLV dispersions in the
presence of EqtII, are shown in Fig. 3. At an EqtII/lipid ratio of
1:1100 mol/mol, several changes to the 31P spectra were observed
when compared to the spectra without toxin (Fig. 1), including the
formation of an additional narrow peak at 0 ppm, which broadened at
higher temperatures, a decrease in the width of the CSA and a loss of
deﬁnition at its edges. The lipid CSAwas 41 and 42 ppmwithout EqtII;
50 and 34 ppm for EqtII:lipid (1:1100); and 48 ppm and ∼30 ppm for
EqtII:lipid (1:250) at 25 and 45 °C, respectively (Table 1). Opposite
effects of EqtII were seen at the two temperatures: at 25 °C the
addition of the toxin resulted in a restriction of the lipid headgroups
whereas an increase in temperature resulted in an accentuated
reduction of the 31P CSA in the presence of EqtII. The exact width of
the CSA could not be determined because of a loss of deﬁnition in the
CSA at higher temperature and could result from changes in T2 [17], as
discussed later. The observed changes in the 31P spectra indicate that
the toxin produces an increase in disorder of the lipid headgroups and
a decrease in size of the MLV at higher temperatures [7].
The isotropic peak at 0 ppm is indicative of almost complete
averaging of the CSA, most likely due to the formation of smaller
vesicles around 100 nm in diameter [24]. At higher temperatures this
peak grew in intensity, indicating an increase in the proportion of
moremobile structures relative to the bulk lipid. Further investigation
of the isotropic peak indicated that there was some residual
phosphate buffer present, but this was only a sharp minor component
at 0 ppm and the increases in intensity with temperature are due to
EqtII interactions. Broadening of the 31P resonance at 0 ppm at higher
temperatures (Fig. 3) suggests that two spectral components may be
merging. This may be due to contributions from a multi-component
system with a range of different sized MLV dispersions between 100
and 2000 nm [25] resulting in a broad range of incompletely averaged
CSA. The effect was reversible when the MLV dispersion was frozen,
suggesting that the small vesicles formed in the more ﬂuid phase can
reform into larger bilayer structures.
2H NMR spectra of the deuterated DMPC in DMPC:SM (1:1) with
EqtII at a 1:1100 and 1:250 toxin/lipid ratios at 25 and 45 °C are
shown in Fig. 3 also. These spectra are very different from those
obtained for the DMPC:SM (1:1) lipid bilayers in the absence of EqtII
Fig. 2. 2H NMR spectra of MLV dispersions at 25 °C and 45 °C.
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be a mixture of components. The spectrum below 35 °C is dominated
by a broad isotropic peak at 0 ppm overlaid on a very broad bilayer
spectrum typical of gel phase lipids. Above 35 °C, the isotropic peak
persisted with a decrease in width, but the underlying spectrum was
characteristic of CD2 quadrupolar splittings of lipids in a liquid
crystalline phase, typical of ﬂuid phase MLV superimposed with
spectra from a range of smaller vesicles. The MLV splittings were
similar for both EqtII ratios, with 27 kHz at 1:1100 and 28 kHz at 1:250
(Table 2). The similarity of the 2H spectra at both toxin/lipid ratios,
suggests that the higher concentration of EqtII does not result in
greater disruption of the lipid acyl chains.
These results differ from the 31P spectra which showed a greater
increase of the isotropic peak at ∼0 ppm with the higher EqtII ratio,
presumably as a consequence of the different timescales of the two
NMR interactions. The 31P CSA is of order 6 kHz, whereas the 90° edge
of the quadrupolar splitting is of order 50 kHz, so faster isotropic
tumbling is needed to average the 2H spectra.
3.3. DMPC:Chol (1:1) and (2:1) in the presence of EqtII
31P spectra of DMPC:Chol (2:1) with EqtII are shown in Fig. 4. The
addition of EqtII at both toxin/lipid ratios resulted in similar two-
component spectra for both DMPC:Chol (1:1) and (2:1). A narrow
peak at 0 ppm characteristic of an isotropic phase was overlaid on a
31P CSA spectrum typical of lipids in a ﬂuid bilayer phase, although the
31P CSA spectra were slightly broadened/rounded relative to the same
lipid compositionwithout EqtII (Fig. 1). Thismay be due to a change inFig. 3. NMR spectra of DMPC:SM (1:1) MLV dispersions in the presence of EqtII at 25 °C
and 45 °C. (Left): 31P spectra, and (Right) 2H spectra.the T2 relaxation rate of the lipid headgroups, which is discussed
below. The isotropic peak, which did not increase with temperature
but did with EqtII concentration, showed a contribution from the
phosphate buffer, as discussed in theMAS section below. Note that the
31P signal was less intense as half of the lipid composition is Chol.
The addition of EqtII had no signiﬁcant effect on the width of the
31P CSA of the bilayer lipids, with a small decrease at 1:1100 and no
change at 1:250 (Table 1), indicating that addition of EqtII resulted in
a negligible change in the disorder of the lipid headgroup when
cholesterol was present. Increasing the temperature to 45 °C had a
small effect on the width of the 31P CSA, which decreased ∼3 ppm
with the addition of EqtII, demonstrating that in the presence of
cholesterol at the higher temperature there was no increased
disruption of the lipids by the toxin.
2H NMR spectra of deuterated DMPC in DMPC:Chol (2:1) following
addition of EqtII are shown in Fig. 4. The 2H spectra also appeared to
arise primarily from two components, with two narrow splittings
around 0 Hz, superimposed on a broader 2H powder pattern,
characteristic of ordered lipids in a ﬂuid bilayer for both DMPC:Chol
(1:1) and (2:1). The splitting, presumably due to the CD3 group at the
end of the lipid acyl chain, decreased with temperature by 24% and
13% at EqtII:lipid ratios of 1:1100 and 1:250, respectively, compared
to that at 25 °C (Table 3, Fig. 5). The methyl splitting for the DMPC:
Chol (2:1) showed a greater decrease, with ∼45 % for 1:1100 and
∼27% for 1:250 EqtII:lipid (Table 3), possibly due to phase separated
lipid induced by the toxin. The addition of EqtII to DMPC:Chol resulted
in an increase in the quadrupolar splitting for EqtII:lipid (1:1100), but
a negligible change for EqtII:lipid (1:250) (Table 2). The increase in
lipid acyl order bestowed by the toxin at lower concentrations was
not seen at higher concentrations, possibly due to formation of toxinTable 1
31P CSA (in ppm)a of MLV with 1:1100 and 1:250 EqtII:lipid.
Lipid composition EqtII:Lipid 25 °C 35 °C 45 °C
DMPC:SM (1:1) Lipid only 41 46 42
DMPC:SM (1:1) 1:1100 50 44 34
DMPC:SM (1:1) 1:250 48 40 n/d
DMPC:Chol (1:1) Lipid only 44 45 45
DMPC:Chol (1:1) 1:1100 42 43 41
DMPC:Chol (1:1) 1:250 44 44 n/d
DMPC:Chol (2:1) Lipid only 49 48 48
DMPC:Chol (2:1) 1:1100 46 43 43
DMPC:Chol (2:1) 1:250 48 n/d 45
DMPC:SM:Chol (1:1:1) Lipid only 52 49 49
DMPC:SM:Chol (1:1:1) 1:1100 46 45 46
DMPC:SM:Chol (1:1:1) 1:250 49 48 n/d
n/d—CSA width not determined due to loss of edge deﬁnition for DMPC:SM (1:1) and
dominance of large isotropic peak for other compositions.
a Uncertainty in CSA ±1 ppm.
Table 2
2H quadrupolar splitting (in kHz) of 90° edge for CD2 of MLV with 1:1100 and 1:250
EqtII:lipid.
Lipid composition EqtII:Lipid 25 °C 35 °C 45 °C
DMPC:SM (1:1) Lipid only 34 29 27
DMPC:SM (1:1) 1:1100 n/d n/d 27
DMPC:SM (1:1) 1:250 n/d 31 28
DMPC:Chol (1:1) Lipid only 55 54 53
DMPC:Chol (1:1) 1:1100 59 55 54
DMPC:Chol (1:1) 1:250 56 54 53
DMPC:Chol (2:1) Lipid only 55 52 47
DMPC:Chol (2:1) 1:1100 57 55 52
DMPC:Chol (2:1) 1:250 55 53 48
DMPC:SM:Chol (1:1:1) Lipid only 57 53 48
DMPC:SM:Chol (1:1:1) 1:1100 56 54 53
DMPC:SM:Chol (1:1:1) 1:250 56 55 51
Uncertainty ∼ ±1 kHz.
n/d—2H splitting values not determined due to lipids in gel phase resulting in a very
broad line shape.
Table 3
CD3 splittings (kHz) for MLV with 1:1100 and 1:250 EqtII:lipid based on the two
innermost peaks either side of the large central peak(s) as shown in Fig. 5.
Lipid composition EqtII:Lipid 25 °C 30 °C 35 °C 40 °C 45 °C
DMPC:SM (1:1) Lipid only 5.2 4.3 3.8 3.3 3.0
DMPC:SM (1:1) 1:1100 – – – – –
DMPC:SM (1:1) 1:250 – – – – –
DMPC:Chol (1:1) Lipid only 7.2 7.0 6.7 6.6 6.5
DMPC:Chol (1:1) 1:1100 3.8 3.7 3.6 2.9 2.7
centrala 1.0 1.0 1.0 0.8 0.7
DMPC:Chol (1:1) 1:250 3.9 3.8 3.6 3.5 3.3
central 1.0 1.0 1.0 1.0 0.9
DMPC:Chol (2:1) Lipid only 8.1 7.7 7.2 6.8 6.2
DMPC:Chol (2:1) 1:1100 4.2 4.1 3.9 3.6 3.6
central 1.0 1.0 1.0 1.0 1.0
DMPC:Chol (2:1) 1:250 5.8 5.6 5.3 4.9 4.6
central 1.2 1.2 1.2 1.0 1.0
DMPC:SM:Chol (1:1:1) Lipid only 9.0 8.8 8.7 8.2 7.4
DMPC:SM:Chol (1:1:1) 1:1100 4.9 4.7 4.4 4.2 4.1
central 1.0 1.0 1.0 0.9 1.0
DMPC:SM:Chol (1:1:1) 1:250 5.6 5.3 5.2 4.6 4.3
central 1.2 1.2 1.1 1.0 1.0
Uncertainty ∼ ±0.1 kHz.
(–) 2H splitting values not determined due presence of a large isotropic peak.
a Central 2H splitting (kHz) labelled (b) in Fig. 5.
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DMPC concentration DMPC:Chol (2:1). Increasing the temperature
did not greatly affect the spectra, but resulted in a decrease in the 2H
quadrupolar splitting similar to that seenwithout EqtII. Upon addition
of EqtII, themethyl splitting decreased signiﬁcantly (Table 3), possibly
due to phase separation whereas the inner splitting ∼1 kHz (Table 3)
is due to the formation of small vesicles.
Comparison of the 31P and 2H spectra showed that at the higher
EqtII concentration, the spectra were more similar to those in the
absence of EqtII. However, at the lower EqtII concentration, the 31P
spectra decreased slightly in width and the 2H spectra increased
slightly in width, which suggests disordering of the headgroups and
ordering of the chains. Also, the presence of narrow peaks in both the
31P and 2H spectra upon addition of EqtII suggests some small vesicle
formation, although not to the extent as when SM is present, which is
consistent with Chol preserving bilayer stability [26,27].
3.4. DMPC:SM:Chol (1:1:1) in the presence of EqtII
31P NMR spectra of DMPC:SM:Chol (1:1:1) following addition of
EqtII are shown in Fig. 6. Again the spectra consist of two components,
a broad 31P CSA characteristic of a ﬂuid bilayer phase in conjunction
with a narrow peak at 0 ppm indicative of an isotropic phase and a
signiﬁcant component due to residual phosphate buffer. At both EqtII
concentrations the 31P CSA becomes rounded as the temperature is
increased from 25 to 45 °C, which could indicate an increase in the T2
relaxation rate as discussed below.Fig. 4. NMR spectra of DMPC:Chol (2:1) MLV dispersions in the presence of EqtII at
25 °C and 45 °C. (Left): 31P spectra, and (Right) 2H spectra.The width of the CSA is reduced from 52 ppm without EqtII to
46 ppm for EqtII:lipid (1:1100) but further addition of EqtII to 1:250
gave a CSA of 49 ppm at 25 °C (Table 1). In the absence of EqtII the
temperature increase reduced the CSA by 3 ppm, whereas for EqtII:
lipid (1:1100) the decrease was negligible. At the higher EqtII
concentration there was a loss of deﬁnition in the CSA edge, which
resulted in the width being difﬁcult to determine at higher
temperature and suggests formation of smaller vesicles as the
temperature increased for both toxin concentrations.
2H NMR spectra of DMPC:SM:Chol (1:1:1) MLV dispersions
following addition of EqtII are shown in Fig. 6. The spectra are similar,
with two narrow peaks around 0 Hz overlaid on a broader 2H powder
pattern from the intact ﬂuid bilayer. There was a small increase in the
isotropic phase when the EqtII concentration was increased. The
methyl splittings decreased by ∼45% (Table 3), possibly from domain
formation induced by the addition of EqtII, and the methyl splitting
decreased by ∼20% at 45 °C (Table 3). The addition of EqtII had a
negligible effect on the width of the 2H bilayer powder pattern at
25 °C, with a splitting of 57 kHz without EqtII and 56 (±1) kHz for
both EqtII concentrations (Table 2). The effect of temperature was
less, with a 9 kHz decrease seen for lipid alone, now only 3 and 5 kHz
(±1 kHz) for EqtII:lipid (1:1100) and (1:250), respectively. This may
be due to domain formation induced by EqtII, which could result in
enrichment or depletion of one or more of the lipids, resulting in a less
ﬂuid bilayer at higher temperatures.
3.5. 31P MAS spectra
MAS NMR of the bilayers at a sufﬁciently high-speed results in the
reduction of the broad CSA to a narrow isotropic component andFig. 5. 2H spectra of DMPC:SM:Chol (1:1:1) with EqtII:lipid (1:1100) at 25 °C showing
the a) CD3 splittings, b) central 2H splitting, and c) 2H2O peak.
Fig. 6. NMR spectra of DMPC:SM:Chol (1:1:1) MLV dispersions in the presence of EqtII.
(Left): 31P spectra, and (Right) 2H spectra.
Fig. 7. 31P MAS spectra of DMPC:SM:Chol (1:1:1) MLV dispersions at 25 °C with EqtII:
lipid ratio (a) nil, (b) 1:1100, and (c) 1:250.
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to examine the differential effect of EqtII on 31P T2 relaxation times of
DMPC and SM. Representative 31P MAS NMR spectra are shown of
DMPC:SM:Chol (1:1:1) MLV dispersions (Fig. 7). Two resonances
were seen without EqtII, whereas three peaks were evident at EqtII:
lipid ratios of 1:1100 and 1:250. The two peaks at−1.0 and−1.5 ppm
are due to the SM and DMPC lipid resonances, respectively. Although
the two phospholipid peaks are of approximately the same intensity,
differences in height are due to differences in width and, therefore,
the T2, the transverse relaxation time. The third, smaller peak at
∼0.5 ppm, which increased with EqtII concentration, arises from
residual phosphate buffer.
3.6. Effect of EqtII on 31P transverse (T2) relaxation times
Changes in the 31P T2 relaxation time are an indication of how low-
frequency motions of the lipid are affected by the toxin. The T2 values
at 25 and 45 °C (Table 4) were calculated from the MAS 31P intensity
as a function of echo delay and ﬁtted well with a single exponential.
Note that at 45 °C both phospholipids would be above the gel–ﬂuid
phase transition temperature, whereas at 25 °C only DMPC is above
the transition temperature.
The presence of cholesterol increased T2 (Table 4), which was also
evident in the reduced linewidth and higher signal intensity of the
cholesterol containing samples. Cholesterol is known to order
phospholipid bilayers, producing a liquid ordered phase [29]. The
effect of EqtII (1:250)was dependent on the lipid composition and the
temperature. The T2 of DMPC in DMPC:Chol (1:1) without EqtII was
39 ms at 25 °C and 33 ms at 45 °C. The value of T2 is longer for MLV
with Chol than for DMPC:SM as a result of the ordering effect of
cholesterol. Upon addition of EqtII to DMPC:Chol (1:1) the T2 at both
temperatures was reduced, but not very signiﬁcantly: 35 ms at 25 °CTable 4
31P MAS T2 relaxation time (ms)a of DMPC and SM in MLV with and without EqtII (1:250).
Lipid composition EqtII:Lipid 25 °C
SM
DMPC:SM (1:1) Lipid only 6.6
DMPC:SM (1:1) 1:250 4.4 (±0.1)
DMPC:Chol (1:1) Lipid only n/a
DMPC:Chol (1:1) 1:250 n/a
DMPC:Chol (2:1) Lipid only n/a
DMPC:Chol (2:1) 1:250 n/a
DMPC:SM:Chol (1:1:1) Lipid only 21.1 (±0.1)
DMPC:SM:Chol (1:1:1) 1:250 23.6 (±1.3)
a The errors are based on the range over at least two experiments.and 28 ms at 45 °C. For DMPC:Chol (2:1), T2 values without EqtII were
less: 23 and 17 ms at 25 and 45 °C, respectively; and with EqtII were
31 ms and 20 ms at 25 and 45 °C, respectively. The toxin appeared to
have modest effect on the more ordered DMPC:Chol (1:1) and to
cause ordering by decreasing the intensity of low-frequency motions
for DMPC:Chol (2:1).
The 31P T2 values of DMPC:SM:Chol (1:1:1) were ∼21 and ∼22 ms
at 25 and 45 °C, respectively. For EqtII (1:250) there was a small
increase in T2 to ∼23 ms at 25 °C (Table 4). However, with EqtII at
45 °C there was a more signiﬁcant decrease in T2 to ∼17 ms. This
suggests a slight ordering effect by the toxin at lower temperature
(below the gel–ﬂuid phase transition of SM, ∼42 °C) and an increase
in slower motions above the SM phase transition temperature. The
EqtII reduced T2 at 45 °C to a greater extent, possibly due to an
increase in SM mobility above its phase transition temperature.
The DMPC and SM peaks in the DMPC:SM (1:1) sample were not
resolved and, therefore, only one T2 value is given.When EqtII (1:250)
was added the phospholipid resonances could be resolved, which is an
indication of different lipid environments for SM and DMPC. The T2
decreased from 6.6 ms to 4.4 and 5.0 ms at 25 °C for SM and DMPC,
respectively, and increased from 3.3 ms to ∼4.5 ms at 45 °C with EqtII.
The toxin appeared to increase the intensity of low-frequency
motions at the lower temperature and to reduce the sensitivity of T2
to temperature for the DMPC:SM bilayers.
3.7. Estimation of EqtII and lipid concentrations
The composition of the supernatant of mixed phospholipid
multilayer samples was investigated to determine if EqtII preferen-
tially removes lipid from the bilayer. 31P NMR spectra of the
supernatant of the MLV samples dissolved in CDCl3/CD3OH (90:10,
v/v) were obtained to determine if EqtII preferentially removed a
speciﬁc lipid from the bilayer. DMPC:SM:Chol (1:1:1) and DMPC:SM
(1:1) with EqtII (1100:1) showed similar peak intensities at−1.0 and
−2.0 ppm for SM and DMPC, respectively, indicating that EqtII did not
preferentially remove either lipid from the bilayer, despite the higher
afﬁnity EqtII has for SM [30].45 °C
DMPC SM DMPC
(±0.3) 3.3 (±0.2)
5.0 (±0.1) 4.5 (±0.1) 4.4 (±0.2)
38.7 (±3.7) n/a 32.6 (±3.8)
35.3 (±0.4) n/a 28.4 (±0.4)
22.8 (±1.1) n/a 17.1 (±0.5)
31.3 (±0.1) n/a 20.4 (±0.4)
21.6 (±0.1) 22.5 (±0.2) 20.8 (±0.8)
22.8 (±0.2) 17.5 (±0.1) 17.1 (±0.3)
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(250:1) prior to and following the static solid-state experiments was
determined using SDS-PAGE by comparison of band intensity against
a standard 1.0 mg/mL EqtII sample. The 100 μL removed immedi-
ately after sample preparation was less concentrated in EqtII
(∼30 μg/ml) than the “supernatant” following NMR spectral
acquisition (∼120 μg/ml). Almost all the EqtII (∼6.3 mg/ml)
appeared to be with the MLV and there was no evidence of EqtII
being preferentially removed from the MLV.
4. Discussion
A comparison of 31P and 2H NMR of lipid systems in the absence of
EqtII shows that the compositions containing cholesterol were more
ordered than DMPC:SM (1:1) dispersions and less affected by
temperature. At 25 °C, the 31P CSA and 2H quadrupolar splittings for
the cholesterol containing lipid dispersions are representative of
phospholipids in the liquid ordered bilayer phase, typical of biological
membrane. The DMPC:SM (1:1) dispersions, however, were in a gel
phase at 25 °C and at higher temperature a small isotropic peak at
0 ppm was evident, indicating the formation of a more disordered
phase and suggesting a more fragile bilayer.
The addition of EqtII resulted in the formation of a signiﬁcant
isotropic peak in the 31P and 2H spectra, which was higher in intensity
than previously reported for DMPC MLV with only 10% SM [7]. The
CSA underneath the isotropic peak showed little change in width
upon addition of EqtII for samples containing Chol but led to a
signiﬁcant reduction for DMPC:SM (1:1). The isotropic peak increased
in intensity and broadened with temperature, and the effect was
reversible. This suggests that the change in lipid morphology was
reversible and, therefore, that the possible formation of vesicles and
budding on the MLV surface was also reversible. Similar 31P results
were seen using total lipid extracts of red blood cells and heart (data
not shown).
Generally, the addition of EqtII had little effect on the width of the
quadrupolar splitting of the 2H powder pattern except for DMPC:Chol
(1:1), which showed a 4 kHz increase in width at the lower EqtII
concentration. This increase in splitting also correlates with the
decrease in 31P T2, as though the toxin was ordering the bilayer and
increasing the phospholipid correlation time. In the absence of EqtII
the 2H quadrupolar splitting decreased with increasing temperature,
but this effect was reduced in the presence of EqtII, suggesting that
EqtII may increase the phase transition temperature and alter the
packing of the lipids.
The effect of EqtII (1:250) on the phospholipid headgroup
dynamics was investigated through the change in the transverse
relaxation times (T2). Cholesterol ordered the bilayer and increased
T2, leading to well resolved spectra, whereas the DMPC:SM bilayers
had broader lines which were better resolved in the presence of EqtII.
The addition of EqtII to the DMPC:SM (1:1) was found to ‘round out’
the spectra, a change which can be associated with the reduction in T2
at 25 °C, for the SM and DMPC peaks. However, at 45 °C the effect was
opposite upon addition of EqtII, possibly due to an increase in the
production of small, highly curved lipid structures as seen in earlier
studies with DMPC and 10% SM [7]. The T2 of DMPC:SM:Chol (1:1:1)
was affected by the addition of EqtII in an opposite manner to DMPC:
SM (1:1), indicating an increase in low-frequency motions at the
higher temperature in the presence of cholesterol, likely due to a
liquid disordered phase [31].
EqtII binds preferentially to the SM-enriched liquid ordered over
the liquid disordered phase and the presence of a domain interface is
required to form pores [13]. This would suggest that EqtII may be in a
pore conformation in the case of DMPC:SM (1:1) and DMPC:SM:Chol
(1:1:1)MLV, in which lipid domains are able to form [32] and be lysed
by EqtII [33]. The 2H methylene and methyl splittings also indicate
phase separation in that, when the toxin is present, the bilayersplittings resemblemore those of a phospholipid bilayer without Chol.
For the liquid ordered bilayers, EqtII led to the formation of smaller
vesicles but in the case of the liquid disordered phase POPC:SM (2:1),
EqtII appeared to form toroidal pores [8]. Although in the latter the
toxin concentration was higher (50:1), EqtII was added to already
formed liposomes whereas in the present study EqtII would be on
both sides of the bilayer. This could lead to the formation of small
vesicles in the DMPC bilayer in the presence of the toxin, which re-
fuse with the larger bilayers, especially with lipids in the liquid
ordered phase [34].
The ability to form small vesicles in MLV correlates with the lytic
activity of the toxin in unilamellar vesicles. Permeabilisation of small
unilamellar vesicles by EqtII [33] has shown that DMPC:SM:Chol
(1:1:1) reaches a higher maximum lysis than DMPC:SM (1:1), which
previously was thought to be the most lytic composition. The solid-
state NMR results indicate that, although the bilayer phase appeared
to bemore stable with cholesterol in the presence of EqtII, when SM is
present greater bilayer disruption occurred. EqtII may be more lytic
due to the formation of domain boundaries when both SM and Chol
are present in lipid bilayers. In summary, EqtII affects the phase
transition temperature of the lipid acyl chains, induces formation of
small vesicle type structures in liquid ordered bilayers with increasing
temperature and changes the dynamics of the phospholipid head-
group. These bilayer disruptions may indirectly relate to the
formation of pores in red blood cell membranes, which occurs at
much lower EqtII concentrations.
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